SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
fangfang
Lv1
30 积分
2022-08-03 加入
最近求助
最近应助
互助留言
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
3小时前
待确认
360P ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib
10天前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
13天前
已完结
Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD
2个月前
已完结
Rituximab in autoimmune pemphigoid diseases: Indications, optimized regimens, and practice gaps
2个月前
已完结
A comprehensive review of SHP2 and its role in cancer
4个月前
已完结
The importance of sample collection when using single cytokine levels and systemic cytokine profiles as biomarkers — a comparative study of serum versus plasma samples
5个月前
已完结
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
5个月前
已完结
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
5个月前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
6个月前
已完结
没有进行任何应助
很抱歉,我需要对的是补充材料,非正文
1年前
可以下载附件么
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论